The Advisory Team at PrimeVax Immuno-Oncology comprises a diverse group of business and scientific experts who provide strategic guidance and insights to drive the development of innovative cancer treatments. They collaborate to assess market trends, shape clinical strategies, and enhance the company's scientific approaches, ensuring that PrimeVax remains at the forefront of immuno-oncology advancements.